G
Gad Getz
Researcher at Broad Institute
Publications - 627
Citations - 309042
Gad Getz is an academic researcher from Broad Institute. The author has contributed to research in topics: Cancer & Biology. The author has an hindex of 189, co-authored 520 publications receiving 247560 citations. Previous affiliations of Gad Getz include University of Colorado Denver & University of California, San Diego.
Papers
More filters
Journal ArticleDOI
Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma
Itay Tirosh,Andrew S. Venteicher,Andrew S. Venteicher,Christine Hebert,Christine Hebert,Leah E. Escalante,Leah E. Escalante,Anoop P. Patel,Keren Yizhak,Keren Yizhak,Jonathan M. Fisher,Christopher Rodman,Christopher Mount,Mariella G. Filbin,Mariella G. Filbin,Cyril Neftel,Cyril Neftel,Niyati Desai,Jackson Nyman,Benjamin Izar,Christina C. Luo,Joshua M. Francis,Joshua M. Francis,Aanand A. Patel,Maristela L. Onozato,Nicolo Riggi,Kenneth J. Livak,David Gennert,Rahul Satija,Brian V. Nahed,William T. Curry,Robert L. Martuza,Ravindra Mylvaganam,A. John Iafrate,Matthew P. Frosch,Todd R. Golub,Todd R. Golub,Todd R. Golub,Miguel Rivera,Miguel Rivera,Gad Getz,Gad Getz,Orit Rozenblatt-Rosen,Daniel P. Cahill,Michelle Monje,Bradley E. Bernstein,Bradley E. Bernstein,David N. Louis,Aviv Regev,Aviv Regev,Mario L. Suvà,Mario L. Suvà +51 more
TL;DR: In this paper, the authors profile 4,347 single cells from six IDH1 or IDH2 mutant human oligodendrogliomas by RNA sequencing and reconstruct their developmental programs from genome-wide expression signatures.
Journal ArticleDOI
The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma
Eliezer M. Van Allen,Eliezer M. Van Allen,Nikhil Wagle,Nikhil Wagle,Antje Sucker,Daniel J. Treacy,Cory M. Johannessen,Eva M. Goetz,Chelsea S. Place,Chelsea S. Place,Amaro Taylor-Weiner,Steven R. Whittaker,Gregory V. Kryukov,Eran Hodis,Eran Hodis,Eran Hodis,Mara Rosenberg,Aaron McKenna,Aaron McKenna,Kristian Cibulskis,Deborah N. Farlow,Lisa Zimmer,Uwe Hillen,Ralf Gutzmer,Simone M. Goldinger,Selma Ugurel,Helen Gogas,Friederike Egberts,Carola Berking,Uwe Trefzer,Carmen Loquai,Benjamin Weide,Jessica C. Hassel,Stacey Gabriel,Scott L. Carter,Gad Getz,Gad Getz,Levi A. Garraway,Levi A. Garraway,Levi A. Garraway,Dirk Schadendorf +40 more
TL;DR: A "long tail" of new mitogen-activated protein kinase (MAPK) pathway alterations (MAP2K2, MITF) that confer RAF inhibitor resistance are discovered that may model subsequent resistance studies of BRAF(V600)-mutant melanoma.
Journal ArticleDOI
Mutations driving CLL and their evolution in progression and relapse.
Dan A. Landau,Eugen Tausch,Amaro Taylor-Weiner,Chip Stewart,Johannes G. Reiter,Jasmin Bahlo,Sandra Kluth,Ivana Bozic,Michael S. Lawrence,Sebastian Böttcher,Scott L. Carter,Scott L. Carter,Kristian Cibulskis,Daniel Mertens,Daniel Mertens,Carrie Sougnez,Mara Rosenberg,Julian M. Hess,Jennifer Edelmann,Sabrina Kless,Michael Kneba,Matthias Ritgen,A. M. Fink,Kirsten Fischer,Stacey Gabriel,Eric S. Lander,Martin A. Nowak,Hartmut Döhner,Michael Hallek,Michael Hallek,Donna Neuberg,Gad Getz,Gad Getz,Stephan Stilgenbauer,Catherine J. Wu +34 more
TL;DR: Large sequencing data sets of clinically informative samples enable the discovery of novel genes associated with cancer, the network of relationships between the driver events, and their impact on disease relapse and clinical outcome.
Journal ArticleDOI
RNA-SeQC
David S. DeLuca,Joshua Z. Levin,Andrey Sivachenko,Timothy Fennell,Marc-Danie Nazaire,Chris Williams,Michael R. Reich,Wendy Winckler,Gad Getz +8 more
TL;DR: RNA-SeQC provides quality control measures critical to experiment design, process optimization and downstream computational analysis, and the modularity of the software enables pipeline integration and the routine monitoring of key measures of data quality.
Journal ArticleDOI
Toil enables reproducible, open source, big biomedical data analyses
John Vivian,Arjun A. Rao,Frank Austin Nothaft,Christopher Ketchum,Joel Armstrong,Adam M. Novak,Jacob Pfeil,Jake Narkizian,Alden Deran,Audrey Musselman-Brown,Hannes Schmidt,Peter Amstutz,Brian Craft,Mary Goldman,Kate R. Rosenbloom,Melissa S. Cline,Brian O'Connor,Megan Hanna,Chet Birger,W. James Kent,David A. Patterson,Anthony D. Joseph,Jingchun Zhu,Sasha Zaranek,Gad Getz,David Haussler,Benedict Paten +26 more
TL;DR: It is envisage that in future individual research laboratories, or clusters of colocated laboratories, will have in-house, low-cost automation work cells but will access DNA foundries via the cloud to carry out complex experimental workflows and accelerate the development and sharing of standardized protocols and metrology standards.